STE · 10-Q · 2026Q3 · Full report
Segment Profitability
STERIS plc · 2026-11-05 · Importance 54 · Surprise 40 · No source text
For the six months ended September 30, 2026, operating income increased 7.0% to $529.4 million in Healthcare, 4.0% to $275.1 million in AST, and 16.0% to $137.5 million in Life Sciences. Healthcare’s six-month operating margin declined to 24.4% from 24.6%, reflecting inflation and operational investment, partly offset by pricing and volume. AST’s margin declined to 46.4% from 47.0% as depreciation, labor costs, and lower productivity outweighed pricing. Life Sciences’ margin rose to 43.3% from 42.3%, with higher volume, productivity, pricing, and mix partly offset by inflation.
Key facts
- STERIS Healthcare operating income increased 3.8% to $269.2 million for the second quarter of fiscal 2027, while operating margin declined to 24.0% from 25.1%, primarily due to inflation, operational investments and lower productivity, partly offset by pricing and volume. source
- STERIS Healthcare operating income increased 7.0% to $529.4 million for the first six months of fiscal 2027, while operating margin declined to 24.4% from 24.6%. source
- STERIS AST operating income increased 4.0% to $275.1 million for the first six months of fiscal 2027, while operating margin declined to 46.4% from 47.0%. source
- STERIS Life Sciences operating income increased 16.0% to $137.5 million for the first six months of fiscal 2027, and operating margin increased to 43.3% from 42.3%. source
- STERIS Life Sciences operating income increased 26.6% to $75.8 million in the second quarter of fiscal 2027, and operating margin increased to 44.4% from 41.3%. source
- STERIS operating income was $294.3 million for the second quarter of fiscal 2027 versus $265.8 million in fiscal 2026, and $580.1 million for the first six months versus $511.8 million; increases reflected pricing, volume and tariff refunds, partly offset by materials and labor costs, higher operational investments and restructuring expenses. source
- STERIS AST operating income increased 3.5% to $132.1 million in the second quarter of fiscal 2027, while operating margin declined to 44.7% from 45.3%. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | positive | realized | +4.3% | STERIS operating income was $294.3 million for the second quarter of fiscal 2027 versus $265.8 million in fiscal 2026, and $580.1 million… |
| margin | positive | realized | +3.1% | STERIS Life Sciences operating income increased 26.6% to $75.8 million in the second quarter of fiscal 2027, and operating margin… |
| operating_income | positive | realized | +2.2% | STERIS Healthcare operating income increased 7.0% to $529.4 million for the first six months of fiscal 2027, while operating margin… |
| operating_income | positive | realized | +1.2% | STERIS Life Sciences operating income increased 16.0% to $137.5 million for the first six months of fiscal 2027, and operating margin… |
| margin | positive | realized | +1.0% | STERIS Life Sciences operating income increased 16.0% to $137.5 million for the first six months of fiscal 2027, and operating margin… |
| operating_income | positive | realized | +1.0% | STERIS Life Sciences operating income increased 26.6% to $75.8 million in the second quarter of fiscal 2027, and operating margin… |
| operating_income | positive | realized | +0.7% | STERIS AST operating income increased 4.0% to $275.1 million for the first six months of fiscal 2027, while operating margin declined to… |
| margin | negative | realized | -0.6% | STERIS AST operating income increased 4.0% to $275.1 million for the first six months of fiscal 2027, while operating margin declined to… |
| margin | negative | realized | -0.2% | STERIS Healthcare operating income increased 7.0% to $529.4 million for the first six months of fiscal 2027, while operating margin… |